Giovanni Brandi

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen et al. · The Lancet Oncology · 2019 · 1.6K citations

Oncology, Hepatology, α-Fetoprotein Concentrations +10

The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses

Valérie Gaboriau‐Routhiau, Sabine Rakotobé, Emelyne Lécuyer et al. · Immunity · 2009 · 1.4K citations · Full text

Biology, Dysbiosis, Key Role +12

Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

Stefano Bellentani, Gioconda Saccoccio, Flora Masutti et al. · Annals of Internal Medicine · 2000 · 1.3K citations

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

ecancermedicalscience

Gauthier Bouche, Nicolás André, Shripad Banavali et al. · ecancermedicalscience · 2016 · 678 citations · Full text

Neuro-oncology, Chemoprevention Strategy, Medicine +12